ArticlePloS one2018

The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer.

Hsin-Hui Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.